JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herrera, R.
Right arrow Articles by Rosen, O. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herrera, R.
Right arrow Articles by Rosen, O. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 263, Issue 12, 5560-5568, 04, 1988

Synthesis, purification, and characterization of the cytoplasmic domain of the human insulin receptor using a baculovirus expression system

R Herrera, D Lebwohl, A Garcia de Herreros, RG Kallen and OM Rosen
Program in Molecular Biology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

The cytoplasmic domain of the beta subunit of the human insulin receptor has been overexpressed in insect cells using the baculovirus expression system. A recombinant baculovirus (BIR-2) was constructed by inserting the human insulin proreceptor cDNA fragment that encodes the cytoplasmic domain of the receptor into the genome of Autographa californica nuclear polyhedrosis virus adjacent to the strong polyhedrin promoter. Synthesis of the protein (baculovirus insulin receptor kinase (BIRK), Mr 48,000) in BIR-2-infected Spodoptera frugiperda (Sf9) cells was detected 24 h after infection and maximal accumulation (2-3% of the cytosolic protein) was achieved 48-72 h post- infection. The expressed protein is active as a soluble protein tyrosine kinase, both in Sf9 cells and in vitro. Rapid purification to near homogeneity was accomplished by sequential chromatography on Fast- Q-Sepharose and phenyl-Superose with an overall yield of 35% and a specific activity with histone as substrate of 20 nmol/min/mg protein. Autophosphorylation activated the intrinsic kinase activity of BIRK and decreased its mobility on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Using a combination of tryptic digestion and immunoprecipitation with specific antipeptide antisera, it was ascertained that 30-40% of the 32P incorporated into BIRK by autophosphorylation is in the carboxyl-terminal domain (that includes tyrosyl residues 1316 and 1322 of the human proreceptor). Of the remaining radioactivity, 75% is in the amino-terminal domain (that includes tyrosyl residues 953, 960, 972, 999, and 1075) and 25% is in the conserved autophosphorylation domain (including tyrosyl residues 1146, 1150, and 1151). Limited digestion of BIRK with trypsin yielded a fragment, Mr 38,000, that lacks the carboxyl-terminal domain. This fragment exhibits protein tyrosine kinase activity that is stimulated by autophosphorylation. The properties of the soluble, monomeric BIRK are similar to those of the intact, activated, oligomeric insulin receptor kinase with respect to specificity, immunoreactivity, divalent cation requirements, and specific activity. These observations coupled with the ease of producing 0.4 mg of purified enzyme from 100 ml of suspension culture suggest that BIRK will be useful for biochemical and biophysical analysis of the insulin receptor protein tyrosine kinase.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Walchli, M.-L. Curchod, R. P. Gobert, S. Arkinstall, and R. H. van Huijsduijnen
Identification of Tyrosine Phosphatases That Dephosphorylate the Insulin Receptor. A BRUTE FORCE APPROACH BASED ON "SUBSTRATE-TRAPPING" MUTANTS
J. Biol. Chem., March 24, 2000; 275(13): 9792 - 9796.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Xu, V. G. Bird, and W. T. Miller
Substrate Specificities of the Insulin and Insulin-like Growth Factor 1 Receptor Tyrosine Kinase Catalytic Domains
J. Biol. Chem., December 15, 1995; 270(50): 29825 - 29830.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Sepp-Lorenzino, Z. Ma, D. E. Lebwohl, A. Vinitsky, and N. Rosen
Herbimycin A Induces the 20 S Proteasome- and Ubiquitindependent Degradation of Receptor Tyrosine Kinases
J. Biol. Chem., July 14, 1995; 270(28): 16580 - 16587.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Wei, S. R. Hubbard, W. A. Hendrickson, and L. Ellis
Expression, Characterization, and Crystallization of the Catalytic Core of the Human Insulin Receptor Protein-tyrosine Kinase Domain
J. Biol. Chem., April 7, 1995; 270(14): 8122 - 8130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Rordorf-Nikolic, D. J. Van Horn, D. Chen, M. F. White, and J. M. Backer
Regulation of Phosphatidylinositol 3`-Kinase by Tyrosyl Phosphoproteins
J. Biol. Chem., February 24, 1995; 270(8): 3662 - 3666.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1988 by the American Society for Biochemistry and Molecular Biology.